Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/1999
08/25/1999CN1226897A Isolated peptides derived from mage-2
08/25/1999CN1226842A Preservation by foam formation
08/25/1999CN1226830A Egg anti-inflammatory composition, method of isolation and use
08/25/1999CN1226829A Method for treating gastrointestinal damage
08/25/1999CN1226442A Medicine for dysmenorrhea and preparing method thereof
08/25/1999CN1226440A Medicine for psoriasis and preparing method thereof
08/25/1999CN1226430A Process for series of health-care capsule from snake
08/25/1999CN1226400A Health-care products 'Xinjifen' made from animal hearts
08/25/1999CN1044780C External-use acupoint paste for hyposensitizing and cough relieving of asthma, and its preparing process
08/25/1999CN1044777C Method for preparing analgesic plaster for cancer pain
08/24/1999US5942496 Methods and compositions for multiple gene transfer into bone cells
08/24/1999US5942437 A culturing system to increase viability and survival of cells by adding a conditioning medium produced by sertoli cells into the culture medium 48 hours prior to cyropreservation or transplantation
08/24/1999US5942434 Regulatory sequence from phophoglycerate kinase operably linked to coding sequence of exogenous gene; for gene therapy; in situ expression of enzymes which convert prodrugs to active anticarcinogenic/antitumor drugs or cytokines
08/24/1999US5942401 An in vitro assay detecting the presence of cytotoxic t-cell response to rev and or tat proteins
08/24/1999US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy
08/24/1999US5942234 Hepatitis C virus asialoglycoproteins
08/24/1999US5942229 Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent
08/24/1999US5942225 Comprising the stem cells and one or more bioactive factors for inducing differentiation of them into a single particular lineage, e.g. bone, muscle, tendon, ligament, connective tissue cells
08/19/1999WO1999041416A2 Compositions comprising viruses and methods for concentrating virus preparations
08/19/1999WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999WO1999041397A1 Anti-viral vectors
08/19/1999WO1999041396A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999WO1999041369A2 Genetic vaccine vector engineering
08/19/1999WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999WO1999041359A1 Modified adenovirus containing a fiber replacement protein
08/19/1999WO1999041274A1 A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions
08/19/1999WO1999040989A1 Natural products from terrestrial and marine sources, and drug discovery based thereon
08/19/1999WO1999040945A2 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
08/19/1999WO1999040924A2 Treatment of neurodegeneration
08/19/1999WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1
08/19/1999WO1999040783A1 Method of controlling proliferation and differentiation of stem and progenitor cells
08/19/1999WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof
08/19/1999WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents
08/19/1999WO1999024074A3 Novel conjugates of opioids and endogenous carriers
08/19/1999WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
08/19/1999CA2723040A1 Compositions comprising viruses and methods for concentrating virus preparations
08/19/1999CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999CA2321135A1 Modified adenovirus containing a fiber replacement protein
08/19/1999CA2321097A1 Anti-viral vectors
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999CA2320302A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
08/18/1999EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
08/18/1999EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY
08/18/1999EP0935605A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
08/18/1999EP0935471A1 Mononuclear phagocytes in therapeutic drug delivery
08/18/1999EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
08/18/1999CN1226170A Preparation of immunostimulating agents based in propionibacteria
08/18/1999CN1225945A DNA encoding neospora dihydrofolate reductase-thymidylate synthase
08/18/1999CN1225835A Oil-state fine medicinal powder preparation for treating carbuncle, sore and preparation method therefor
08/18/1999CN1225831A Pile-diminishing capsule
08/18/1999CN1225828A External-use medicine for treating burn and scald of humanbody
08/18/1999CN1225824A Diagnosis and treatment and health-care medicinal liquor of external use for the five sense organs
08/18/1999CN1225822A Medicines and feed for fishes, shellfishes and animals and medicines for plants
08/18/1999CN1225821A Earthworm thrombus-dissolving enzyme injection for treating acute thrombus diseases and preparation method therefor
08/18/1999CN1225820A Preparation method for honeybee placenta element and honeybee cocoon element, and use thereof
08/18/1999CN1225819A Devitalization method for bone-matrix gelatin carrier
08/18/1999CN1044686C Medicine for curing stomach disease
08/17/1999US5939404 Anticarcinogenic agents and antitumor agents
08/17/1999US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999US5939023 Fibrinogen processing apparatus method and container
08/17/1999US5938923 Microfabricated filter and capsule using a substrate sandwich
08/17/1999CA2121834C A container for receiving and separating a fluid, preferably blood plasma, into its ingredients
08/12/1999WO1999040180A2 Expanded and genetically modified populations of human hematopoietic stem cells
08/12/1999WO1999039735A1 Live vaccine for human immunodeficiency virus
08/12/1999WO1999039729A2 Use of heregulin as an epithelial cell growth factor
08/12/1999WO1999039727A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999WO1999039726A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999WO1999039724A1 Treatment of bony defects with osteoblast precursor cells
08/12/1999WO1999026589A3 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
08/12/1999WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999WO1999018226A9 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
08/12/1999WO1999015684A8 Expression of genes in hematopoietic stem cells in hischaemic conditions
08/12/1999CA2320489A1 Live vaccine for human immunodeficiency virus
08/12/1999CA2319764A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999CA2319448A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999CA2318857A1 Use of heregulin as an epithelial cell growth factor
08/12/1999CA2318819A1 Expanded and genetically modified populations of human hematopoietic stem cells
08/11/1999EP0934427A1 Rh blood group antigen compositions and methods of use
08/11/1999EP0934422A2 Gene therapy for congestive heart failure
08/11/1999EP0934416A1 Feline polynucleotide vaccine formula
08/11/1999EP0934411A1 Compositions for treating anemia
08/11/1999EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999EP0934340A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934073A1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition
08/11/1999EP0785987B1 Flow through electroporation apparatus and method
08/11/1999EP0759032B1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
08/11/1999EP0699240B1 Gibbon ape leukemia virus-based retroviral vectors
08/11/1999CN1225591A Membrane incorporation of texaphyrins
08/11/1999CN1225556A Animal feed
08/11/1999CN1225276A Drug for radical curing dental caries
08/11/1999CN1225273A Health-care traditional Chinese medicine, and method for preparing same
08/11/1999CN1225271A Pearl eyesight improvement drops contg vitamin C
08/11/1999CN1225270A Pearl eyesight improvement powder medicine contg. vitamin C
08/11/1999CN1225264A Drug for curing diabetes and method for preparing same
08/11/1999CN1225239A Edible health-care fish oil with no fishy smell
08/11/1999CN1044566C Traditional Chinese proprietary medicine for treating rheumatoid disease
08/11/1999CN1044564C Analgesic ointment